Activity value 62china Buyer&Supplier,Last transaction date:
2019-10-25
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for jiangsu yew pharmaceutical co.ltd. from 2018 to 2019.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2019, the company has completed 25 transactions, with a transaction quantity of 146 and a transaction weight of 0.
YearTransactionsQuantityWeight
201810410
2019251460
Bill of lading data
<
1/15
>
Trade date
2019/10/25
B/L No.
——
Suppliers
jiangsu yew pharmaceutical co.ltd.
Buyers
puja enterprises
POLs
——
PODs
sahar air cargo acc inbom4
Supply area
China
Purchas area
India
Weight
——
Amount
227000
Hs code
29339900
Product tags
paclitaxel,ip usp
Product description
PACLITAXEL IP USP
Expand
Trade date
2019/10/25
B/L No.
——
Suppliers
jiangsu yew pharmaceutical co.ltd.
Buyers
ketan pharma
POLs
——
PODs
sahar air cargo acc inbom4
Supply area
China
Purchas area
India
Weight
——
Amount
113000
Hs code
29339900
Product tags
paclitaxel
Product description
PACLITAXEL IP/USP
Expand
Trade date
2019/10/23
B/L No.
——
Suppliers
jiangsu yew pharmaceutical co.ltd.
Buyers
helios lifesciences ltd.
jiangsu yew pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as paclitaxel,bd,ip usp.
According to the 52wmb.com global trade database, as of 2019-10-25, the company has completed 94 international trades,
with its main trading regions covering india,ecuador,united states etc.
The core products include HS29339900,HS29329900 etc,
often transported via beijing nanyuan,port hangzhou etc,
and its main trading partners are ketan pharma,puja enterprises,venus remedies ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jiangsu yew pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.